Novozymes A/S (OTCMKTS:NVZMY) Stock Crosses Above 50-Day Moving Average – Should You Sell?

Novozymes A/S (OTCMKTS:NVZMY) shares crossed above its 50-day moving average during trading on Friday . The stock has a 50-day moving average of $61.13 and traded as high as $62.72. Novozymes A/S shares last traded at $62.44, with a volume of 22,274 shares changing hands.

Analyst Ratings Changes

NVZMY has been the topic of several research analyst reports. Kepler Capital Markets raised shares of Novozymes A/S from a “hold” rating to a “strong-buy” rating in a report on Wednesday, May 13th. Zacks Research raised Novozymes A/S from a “strong sell” rating to a “hold” rating in a research note on Monday, June 8th. Two analysts have rated the stock with a Strong Buy rating and one has issued a Hold rating to the stock. Based on data from MarketBeat, Novozymes A/S presently has a consensus rating of “Buy”.

Novozymes A/S Stock Performance

The company’s 50-day moving average is $61.13 and its two-hundred day moving average is $60.47. The company has a market capitalization of $25.88 billion, a P/E ratio of 42.19, a PEG ratio of 2.92 and a beta of 0.92. The company has a quick ratio of 1.03, a current ratio of 1.67 and a debt-to-equity ratio of 0.27.

Novozymes A/S (OTCMKTS:NVZMY) last announced its earnings results on Tuesday, May 5th. The biotechnology company reported $0.51 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.82 by ($0.31). Novozymes A/S had a net margin of 14.22% and a return on equity of 6.52%. The company had revenue of $1.31 billion for the quarter, compared to the consensus estimate of $1.32 billion. Equities analysts anticipate that Novozymes A/S will post 2.43 earnings per share for the current fiscal year.

About Novozymes A/S

Novozymes A/S is a Danish biotechnology company that develops, produces and markets industrial enzymes and microorganisms. Headquartered in Bagsværd, Denmark, the company focuses on using biological solutions to improve industrial processes across a range of end markets. Its offerings are designed to increase product performance or process efficiency while reducing energy, water and chemical consumption for customers.

The company’s product portfolio includes enzymes and microbial solutions for household care (detergents and cleaning products), food and beverages (baking, brewing and dairy applications), bioenergy (enzymes for biofuel production), agriculture (microbial crop inputs and biocontrols) and industrial processing (textiles, pulp and paper, and wastewater treatment).